StreetInsider.com News Articles

StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 17 Apr 2026 08:59:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Form 8-K Lyra Therapeutics, Inc. For: Apr 13 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+13/26328190.html si-local-file:///var/storage/secattach/20260417/26328190.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+13/26328190.html Fri, 17 Apr 2026 08:59:00 -0400 LYRA Lyra Therapeutics to delist from NASDAQ, file deregistration http://www.streetinsider.com/Corporate+News/Lyra+Therapeutics+to+delist+from+NASDAQ%2C+file+deregistration/26327844.html <p>Lyra Therapeutics, Inc. announced its intention to voluntarily file a Form 25 Notification of Delisting with the Securities and Exchange Commission on April 20, 2026, to remove its common stock from listing and registration on NASDAQ.</p><p>Trading in the company's common stock was suspended by NASDAQ on March 17, 2026. The company stated that while NASDAQ has indicated it intends to file its own Form 25 after internal procedural periods conclude, it has not yet done so. Lyra Therapeutics is therefore proceeding with a voluntary filing to advance the deregistration process.</p><p>The company's common stock is currently quoted on the Pink Limited http://www.streetinsider.com/Corporate+News/Lyra+Therapeutics+to+delist+from+NASDAQ%2C+file+deregistration/26327844.html Fri, 17 Apr 2026 08:01:05 -0400 LYRA Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Press+Releases/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Lyra Therapeutics, Inc. Announces Intention to Voluntarily File Form 25 for Delisting from Nasdaq and Subsequent Deregistration with the SEC http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html <p>WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (the "Company") today announced its intention to voluntarily file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission (the "SEC") on Monday, April 20, 2026, to remove its common stock from listing and registration on The Nasdaq Stock Market LLC ("Nasdaq"). As previously disclosed, trading in the Company's common stock was suspended by Nasdaq on March 17, 2026. Although Nasdaq has indicated it intends to file its own Form 25 after all internal procedural periods have run, it has not yet done so. http://www.streetinsider.com/Globe+Newswire/Lyra+Therapeutics%2C+Inc.+Announces+Intention+to+Voluntarily+File+Form+25+for+Delisting+from+Nasdaq+and+Subsequent+Deregistration+with+the+SEC/26327814.html Fri, 17 Apr 2026 08:00:00 -0400 A.50216776 LYRA LYRA O.04855546 O.29783969 Form 8-K Lyra Therapeutics, Inc. For: Mar 31 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Mar+31/26298144.html si-local-file:///var/storage/secattach/20260410/26298144.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Mar+31/26298144.html Fri, 10 Apr 2026 08:59:00 -0400 LYRA O.04855546 Form 8-K Lyra Therapeutics, Inc. For: Mar 31 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Mar+31/26298144.html si-local-file:///var/storage/secattach/20260410/26298144.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Mar+31/26298144.html Fri, 10 Apr 2026 08:59:00 -0400 LYRA O.04855546 Form 4 Lyra Therapeutics, Inc. For: Apr 01 Filed by: Cavalier Jason http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Cavalier+Jason/26271695.html si-local-file:///var/storage/secattach/20260403/26271695.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Cavalier+Jason/26271695.html Fri, 03 Apr 2026 16:05:00 -0400 LYRA O.04855546 Form 4 Lyra Therapeutics, Inc. For: Apr 01 Filed by: Cavalier Jason http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Cavalier+Jason/26271695.html si-local-file:///var/storage/secattach/20260403/26271695.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Cavalier+Jason/26271695.html Fri, 03 Apr 2026 16:05:00 -0400 LYRA O.04855546 Form 4 Lyra Therapeutics, Inc. For: Apr 01 Filed by: Palasis Maria http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Palasis+Maria/26271705.html si-local-file:///var/storage/secattach/20260403/26271705.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Palasis+Maria/26271705.html Fri, 03 Apr 2026 16:05:00 -0400 LYRA O.04855546 Form 4 Lyra Therapeutics, Inc. For: Apr 01 Filed by: Palasis Maria http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Palasis+Maria/26271705.html si-local-file:///var/storage/secattach/20260403/26271705.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Apr+01++Filed+by%3A+Palasis+Maria/26271705.html Fri, 03 Apr 2026 16:05:00 -0400 LYRA O.04855546 Form 10-K Lyra Therapeutics, Inc. For: Dec 31 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Dec+31/26252541.html si-local-file:///var/storage/secattach/20260331/26252541.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Dec+31/26252541.html Tue, 31 Mar 2026 17:17:00 -0400 LYRA O.04855546 Form 10-K Lyra Therapeutics, Inc. For: Dec 31 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Dec+31/26252541.html si-local-file:///var/storage/secattach/20260331/26252541.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++Lyra+Therapeutics%2C+Inc.+++For%3A+Dec+31/26252541.html Tue, 31 Mar 2026 17:17:00 -0400 LYRA O.04855546 Form EFFECT Lyra Therapeutics, Inc. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227496.html si-local-file:///var/storage/secattach/20260327/26227496.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227496.html Fri, 27 Mar 2026 06:05:00 -0400 LYRA O.04855546 Form EFFECT Lyra Therapeutics, Inc. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227496.html si-local-file:///var/storage/secattach/20260327/26227496.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227496.html Fri, 27 Mar 2026 06:05:00 -0400 LYRA O.04855546 Form EFFECT Lyra Therapeutics, Inc. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227508.html si-local-file:///var/storage/secattach/20260327/26227508.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227508.html Fri, 27 Mar 2026 06:05:00 -0400 LYRA O.04855546 Form EFFECT Lyra Therapeutics, Inc. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227508.html si-local-file:///var/storage/secattach/20260327/26227508.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227508.html Fri, 27 Mar 2026 06:05:00 -0400 LYRA O.04855546 Form EFFECT Lyra Therapeutics, Inc. http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227521.html si-local-file:///var/storage/secattach/20260327/26227521.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Lyra+Therapeutics%2C+Inc.++++++++++++++/26227521.html Fri, 27 Mar 2026 06:05:00 -0400 LYRA O.04855546